On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled in the first trial of the first experimental vaccine candidate for the COVID-19 virus.

As the trial expanded to include a total of 105 healthy adults, KPWHRI’s vaccine research team included 20 healthy Seattle-area participants age 71 years and older.